637-58-1
Chemical Structure
Pramocaine hydrochloride
Synonym(s): Pramoxine hydrochloride
- CAS No.: 637-58-1
- Formula:C17H28ClNO3
- Molecular Weight:329.86
IUPAC Name: 4-(3-(4-butoxyphenoxy)propyl)morpholine hydrochloride
InChIKey: SYCBXBCPLUFJID-UHFFFAOYSA-N
SMILES: CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1.[H]Cl
Biological Activity: Pramocaine (Pramoxine) hydrochloride is a topical surface anesthetic and antipruritic agent. Pramocaine hydrochloride reversibly inhibits voltage-gated sodium channel, reduces transmembrane permeability of sodium ions, stabilizes cell membranes, prevents depolarization, blocks action potential conduction, and inhibits peripheral slow C-fiber pathways associated with pain, pruritus and thermoception. Pramocaine hydrochloride can be used in research related to chronic pruritus, renal pruritus, atopic dermatitis, xerotic pruritus, uremic pruritus, and cutaneous hyperalgesia/pain[1][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Pramocaine hydrochloride | 99.85% | Pramocaine (Pramoxine) hydrochloride is a topical surface anesthetic and antipruritic agent. Pramocaine hydrochloride reversibly inhibits voltage-gated sodium channel, reduces transmembrane permeability of sodium ions, stabilizes cell membranes, prevents depolarization, blocks action potential conduction, and inhibits peripheral slow C-fiber pathways associated with pain, pruritus and thermoception. Pramocaine hydrochloride can be used in research related to chronic pruritus, renal pruritus, atopic dermatitis, xerotic pruritus, uremic pruritus, and cutaneous hyperalgesia/pain. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pramocaine hydrochloride (Standard) | ≥98% | Pramocaine (Pramoxine) hydrochloride (Standard) is the analytical standard of Pramocaine hydrochloride (HY-B1319). This product is intended for research and analytical applications. Pramocaine hydrochloride is a topical surface anesthetic and antipruritic agent. Pramocaine hydrochloride reversibly inhibits voltage-gated sodium channel, reduces transmembrane permeability of sodium ions, stabilizes cell membranes, prevents depolarization, blocks action potential conduction, and inhibits peripheral slow C-fiber pathways associated with pain, pruritus and thermoception. Pramocaine hydrochloride can be used in research related to chronic pruritus, renal pruritus, atopic dermatitis, xerotic pruritus, uremic pruritus, and cutaneous hyperalgesia/pain. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pramocaine-d9 hydrochloride | Pramocaine-d9 (Pramoxine-d9) hydrochloride is the d9-labeled Pramocaine hydrochloride (HY-B1319). Pramocaine hydrochloride is a topical surface anesthetic and antipruritic agent. Pramocaine hydrochloride reversibly inhibits voltage-gated sodium channel, reduces transmembrane permeability of sodium ions, stabilizes cell membranes, prevents depolarization, blocks action potential conduction, and inhibits peripheral slow C-fiber pathways associated with pain, pruritus and thermoception. Pramocaine hydrochloride can be used in research related to chronic pruritus, renal pruritus, atopic dermatitis, xerotic pruritus, uremic pruritus, and cutaneous hyperalgesia/pain. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.98
HY-167645Pramocaine -
Similarity Score 0.69
HY-124389UCL-1972 -
Similarity Score 0.69
HY-114745MoTP -
Similarity Score 0.68
HY-120719SB 201823-A -
Similarity Score 0.67
HY-W0354124-((5-(4-Ethoxyphenoxy)pentyl)oxy)aniline -
Similarity Score 0.67
HY-Z06726,6'-(1,4-Phenylenebis(oxy))bis(hexan-1-ol) -
Similarity Score 0.66
HY-U00066Cicloprolol hydrochloride -
Similarity Score 0.66
HY-23312Antiparasitic agent-41 -
Similarity Score 0.66
HY-181649S1R agonist 3 -
Explore the MedChemAI to find more analogs
References
-
[1]. Agarwal A, et al. Topical Pramoxine in Chronic Pruritus: Where do We Stand? Indian J Dermatol. 2021 Sep-Oct;66(5):576.
[Content Brief] - [3]. Chou AK, et al. Skin nociceptive block with pramoxine delivery by subcutaneous injection in rats. Pharmacological reports : PR. 2018 Dec;70(6):1180-1184. [Content Brief]
